Sevgi Bilgen
Research Subjects
Sevgi Bilgen has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Dilek Erdogan
Department of Anesthesiology, Acibadem Kozyatagi Hospital, Istanbul, Turkey
3 shared publications- Safak Karacay
Pediatric Surgery Clinic, Faculty of Medicine, Yeditepe University, İstanbul, Turkey
3 shared publications - Dilek Erdogan Ari
Clinic of Anaesthesiology and Reanimation, Fatih Sultan Mehmet Training and Research Hospital, İstanbul, Turkey
2 shared publications Elif Cigdem Kaspar
Department of Biostatistics, Faculty of Medicine, Yeditepe University, Istanbul, Turkey
2 shared publicationsSabri Berkem Ökten
Department of Obstetrics and Gynecology, Acibadem Kozyatagi Hospital, Istanbul, Turkey
2 shared publications- Selami Sözübir
Department of Urology, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9110, USA
2 shared publications
Latest Publications
- Open Access
- 18 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 40568
Progestin primed ovarian stimulation yields comparable outcomes to the GnRH antagonist protocol for controlled ovarian hyperstimulation
To prevent the occurrence of a luteinizing hormone surge during assisted reproductive technology cycles, clinicians commonly utilize gonadotropin-releasing hormone (GnRH) analogues or progestin. However, there is a paucity of data directly comparing the reliability and efficacy of these strategies. This retrospective study compares ovarian stimulation outcomes in intracytoplasmic sperm injection (ICSI) cycles using either a progestin-primed ovarian stimulation (PPOS) protocol or a GnRH antagonist protocol for controlled ovarian hyperstimulation, conducted between January 2022 and November 2023. A total of 385 patients were analyzed, with 150 receiving the PPOS protocol and 235 receiving the GnRH antagonist protocol. There were no significant differences in oocyte yield, embryo quality, fertilization rates, or pregnancy outcomes between the two groups. Multiple regression analysis revealed that the type of stimulation protocol was not associated with live birth rates (LBR). However, longer infertility duration (p = 0.011) and diminished ovarian reserve (p < 0.001) were linked to lower LBR. Conversely, a higher number of good-quality embryos (p = 0.003), increased blastocyst formation rates (p = 0.003), and two-embryo transfers (p = 0.003) were associated with improved LBR. These findings suggest that the PPOS protocol is an effective approach for ovarian stimulation in ICSI cycles, demonstrating comparable outcomes to GnRH antagonists across multiple outcome measures.
- 18 November 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 40568
Open AccessProgestin primed ovarian stimulation yields comparable outcomes to the GnRH antagonist protocol for controlled ovarian hyperstimulation
To prevent the occurrence of a luteinizing hormone surge during assisted reproductive technology cycles, clinicians commonly utilize gonadotropin-releasing hormone (GnRH) analogues or progestin. However, there is a paucity of data directly comparing the reliability and efficacy of these strategies. This retrospective study compares ovarian stimulation outcomes in intracytoplasmic sperm injection (ICSI) cycles using either a progestin-primed ovarian stimulation (PPOS) protocol or a GnRH antagonist protocol for controlled ovarian hyperstimulation, conducted between January 2022 and November 2023. A total of 385 patients were analyzed, with 150 receiving the PPOS protocol and 235 receiving the GnRH antagonist protocol. There were no significant differences in oocyte yield, embryo quality, fertilization rates, or pregnancy outcomes between the two groups. Multiple regression analysis revealed that the type of stimulation protocol was not associated with live birth rates (LBR). However, longer infertility duration (p = 0.011) and diminished ovarian reserve (p < 0.001) were linked to lower LBR. Conversely, a higher number of good-quality embryos (p = 0.003), increased blastocyst formation rates (p = 0.003), and two-embryo transfers (p = 0.003) were associated with improved LBR. These findings suggest that the PPOS protocol is an effective approach for ovarian stimulation in ICSI cycles, demonstrating comparable outcomes to GnRH antagonists across multiple outcome measures.
- 23 October 2024
- Published by Elsevier in Journal of Voice
Morphometric Examination of the Larynx in Turkish Population
- 23 October 2024
- Published by Elsevier in Journal of Voice
Morphometric Examination of the Larynx in Turkish Population
- Open Access
- 6 December 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-8
Infusion of propofol with bispectral index monitoring does not reduce the amount of propofol used during transvaginal oocyte retrieval procedure
In our study we aimed to investigate whether the use of bispectral index (BIS) monitoring would decrease total propofol consumption during the transvaginal oocyte retrieval procedure. This was a prospective, randomized, controlled, parallel-group clinical trial. The study was conducted in the operating room, and postoperative recovery room. One hundred and thirty, American Society of Anesthesiologists (ASA) I–II patients, over age 18, undergoing transvaginal oocyte retrieval were included in this study. All patients were administered 2 μg/kg fentanyl, and 2 mg/kg propofol for the induction of anesthesia. The patients were divided into two groups. Patients in the group bolus were given 0.5 mg/kg of propofol when necessary, according to the observer's range of motion. Patients in the group BIS were given 10 mg/kg/h propofol infusion adjusted to keep the BIS value between 40 and 60. The primary outcome was the total dose of propofol administered per patient. The secondary outcomes were the time to reach the value of 5 on the Modified Observer's Assessment of Alertness Sedation Scale (MOASs), the time to reach Post Anesthetic Discharge Scoring System (PADSS) ≥ 9 of the patients, satisfaction of the patient, and the gynecologist. The amount of total propofol was higher in the group BIS than in the group bolus administered according to the patient's clinic. There was no difference in the time to reach the value of 5 on the MOASs between the groups. The time to reach PADSS ≥ 9 was longer in the group BIS than in the group bolus. There was no difference between the two groups in terms of the satisfaction of the patient and the gynecologist. Administration of propofol as an infusion with BIS monitoring did not reduce the amount of propofol administered to patients during transvaginal oocyte retrieval.Clinical trial registration number: NCT05631925—30/11/2022.
- 6 December 2023
- Published by Springer Nature in Scientific Reports
- Vol. 13 (1) , 1-8
Open AccessInfusion of propofol with bispectral index monitoring does not reduce the amount of propofol used during transvaginal oocyte retrieval procedure
In our study we aimed to investigate whether the use of bispectral index (BIS) monitoring would decrease total propofol consumption during the transvaginal oocyte retrieval procedure. This was a prospective, randomized, controlled, parallel-group clinical trial. The study was conducted in the operating room, and postoperative recovery room. One hundred and thirty, American Society of Anesthesiologists (ASA) I–II patients, over age 18, undergoing transvaginal oocyte retrieval were included in this study. All patients were administered 2 μg/kg fentanyl, and 2 mg/kg propofol for the induction of anesthesia. The patients were divided into two groups. Patients in the group bolus were given 0.5 mg/kg of propofol when necessary, according to the observer's range of motion. Patients in the group BIS were given 10 mg/kg/h propofol infusion adjusted to keep the BIS value between 40 and 60. The primary outcome was the total dose of propofol administered per patient. The secondary outcomes were the time to reach the value of 5 on the Modified Observer's Assessment of Alertness Sedation Scale (MOASs), the time to reach Post Anesthetic Discharge Scoring System (PADSS) ≥ 9 of the patients, satisfaction of the patient, and the gynecologist. The amount of total propofol was higher in the group BIS than in the group bolus administered according to the patient's clinic. There was no difference in the time to reach the value of 5 on the MOASs between the groups. The time to reach PADSS ≥ 9 was longer in the group BIS than in the group bolus. There was no difference between the two groups in terms of the satisfaction of the patient and the gynecologist. Administration of propofol as an infusion with BIS monitoring did not reduce the amount of propofol administered to patients during transvaginal oocyte retrieval.Clinical trial registration number: NCT05631925—30/11/2022.
- Open Access
- 27 March 2023
- Published by Springer Nature in Research Square
The Effect of Using Bispectral Index Monitoring on the Amount of Propofol Used During Transvaginal Oocyte Retrieval Procedure: a Prospective, Randomized, Controlled, Clinical Trial
Objective: To investigate whether the use of bispectral index (BIS) monitoring would decrease total propofol consumption during the transvaginal oocyte retrieval procedure Design: Prospective, randomized, controlled, parallel-group clinical trial Setting: Operating room, postoperative recovery room Population: One hundred and thirty, American Society of Anesthesiologists (ASA) I-II patients, over age 18, undergoing transvaginal oocyte retrieval Methods: All patients were administered 2mg/kg fentanyl, and 2mg/kg propofol for the induction of anesthesia. The patients were divided into two groups. Patients in the group bolus were given 0.5 mg/kg of propofol when necessary, according to the observer's range of motion. Patients in the group BIS were given 10 mg/kg/hour propofol infusion adjusted to keep the BIS value between 40-60. Main Outcome Measures: The primary outcome was the total dose of propofol administered per patient. The secondary outcomes were the time to reach the value of 5 on the Modified Observer's Assessment of Alertness Sedation Scale (MOASs), the time to reach Post Anesthetic Discharge Scoring System (PADSS) ³9 of the patients, satisfaction of the patient, and the gynecologist. Results: The amount of total propofol was higher in the group BIS than in the group bolus administered according to the patient's clinic. There was no difference in the time to reach the value of 5 on the MOASs between the groups. The time to reach PADSS ³9 was longer in the group BIS than in the group bolus. There was no difference between the two groups in terms of the satisfaction of the patient and the gynecologist. Conclusion: Administration of propofol as an infusion with BIS monitoring did not reduce the amount of propofol administered to patients during transvaginal oocyte retrieval. IRB number: The Clinical Research Ethics Committee of Acıbadem University, Istanbul, Turkey (No:2022/05-32). Clinical trial registration number: NCT05631925 - 12/03/2022
- 27 March 2023
- Published by Springer Nature in Research Square
Open AccessThe Effect of Using Bispectral Index Monitoring on the Amount of Propofol Used During Transvaginal Oocyte Retrieval Procedure: a Prospective, Randomized, Controlled, Clinical Trial
Objective: To investigate whether the use of bispectral index (BIS) monitoring would decrease total propofol consumption during the transvaginal oocyte retrieval procedure Design: Prospective, randomized, controlled, parallel-group clinical trial Setting: Operating room, postoperative recovery room Population: One hundred and thirty, American Society of Anesthesiologists (ASA) I-II patients, over age 18, undergoing transvaginal oocyte retrieval Methods: All patients were administered 2mg/kg fentanyl, and 2mg/kg propofol for the induction of anesthesia. The patients were divided into two groups. Patients in the group bolus were given 0.5 mg/kg of propofol when necessary, according to the observer's range of motion. Patients in the group BIS were given 10 mg/kg/hour propofol infusion adjusted to keep the BIS value between 40-60. Main Outcome Measures: The primary outcome was the total dose of propofol administered per patient. The secondary outcomes were the time to reach the value of 5 on the Modified Observer's Assessment of Alertness Sedation Scale (MOASs), the time to reach Post Anesthetic Discharge Scoring System (PADSS) ³9 of the patients, satisfaction of the patient, and the gynecologist. Results: The amount of total propofol was higher in the group BIS than in the group bolus administered according to the patient's clinic. There was no difference in the time to reach the value of 5 on the MOASs between the groups. The time to reach PADSS ³9 was longer in the group BIS than in the group bolus. There was no difference between the two groups in terms of the satisfaction of the patient and the gynecologist. Conclusion: Administration of propofol as an infusion with BIS monitoring did not reduce the amount of propofol administered to patients during transvaginal oocyte retrieval. IRB number: The Clinical Research Ethics Committee of Acıbadem University, Istanbul, Turkey (No:2022/05-32). Clinical trial registration number: NCT05631925 - 12/03/2022
- Open Access
- 2 February 2023
- Published by Wiley
THE EFFECT OF USING BISPECTRAL INDEX MONITORING ON THE AMOUNT OF PROPOFOL USED DURING TRANSVAGINAL OOCYTE RETRIEVAL PROCEDURE: A PROSPECTIVE, RANDOMIZED, CONTROLLED, CLINICAL TRIAL
Objective: To investigate whether the use of bispectral index (BIS) monitoring would decrease total propofol consumption during the transvaginal oocyte retrieval procedure Design: Prospective, randomized, controlled, parallel-group clinical trial Setting: Operating room, postoperative recovery room Population: One hundred and thirty, American Society of Anesthesiologists (ASA) I-II patients, over age 18, undergoing transvaginal oocyte retrieval Methods: All patients were administered 2μg/kg fentanyl, and 2mg/kg propofol for the induction of anesthesia. The patients were divided into two groups. Patients in the group bolus were given 0.5 mg/kg of propofol when necessary, according to the observer’s range of motion. Patients in the group BIS were given 10 mg/kg/hour propofol infusion adjusted to keep the BIS value between 40-60. Main Outcome Measures: The primary outcome was the total dose of propofol administered per patient. The secondary outcomes were the time to reach the value of 5 on the Modified Observer’s Assessment of Alertness Sedation Scale (MOASs), the time to reach Post Anesthetic Discharge Scoring System (PADSS) ≥9 of the patients, satisfaction of the patient, and the gynecologist. Results: The amount of total propofol was higher in the group BIS than in the group bolus administered according to the patient’s clinic. There was no difference in the time to reach the value of 5 on the MOASs between the groups. The time to reach PADSS ≥9 was longer in the group BIS than in the group bolus. There was no difference between the two groups in terms of the satisfaction of the patient and the gynecologist. Conclusion: Administration of propofol as an infusion with BIS monitoring did not reduce the amount of propofol administered to patients during transvaginal oocyte retrieval. Funding: This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors.
- 2 February 2023
- Published by Wiley
Open AccessTHE EFFECT OF USING BISPECTRAL INDEX MONITORING ON THE AMOUNT OF PROPOFOL USED DURING TRANSVAGINAL OOCYTE RETRIEVAL PROCEDURE: A PROSPECTIVE, RANDOMIZED, CONTROLLED, CLINICAL TRIAL
Objective: To investigate whether the use of bispectral index (BIS) monitoring would decrease total propofol consumption during the transvaginal oocyte retrieval procedure Design: Prospective, randomized, controlled, parallel-group clinical trial Setting: Operating room, postoperative recovery room Population: One hundred and thirty, American Society of Anesthesiologists (ASA) I-II patients, over age 18, undergoing transvaginal oocyte retrieval Methods: All patients were administered 2μg/kg fentanyl, and 2mg/kg propofol for the induction of anesthesia. The patients were divided into two groups. Patients in the group bolus were given 0.5 mg/kg of propofol when necessary, according to the observer’s range of motion. Patients in the group BIS were given 10 mg/kg/hour propofol infusion adjusted to keep the BIS value between 40-60. Main Outcome Measures: The primary outcome was the total dose of propofol administered per patient. The secondary outcomes were the time to reach the value of 5 on the Modified Observer’s Assessment of Alertness Sedation Scale (MOASs), the time to reach Post Anesthetic Discharge Scoring System (PADSS) ≥9 of the patients, satisfaction of the patient, and the gynecologist. Results: The amount of total propofol was higher in the group BIS than in the group bolus administered according to the patient’s clinic. There was no difference in the time to reach the value of 5 on the MOASs between the groups. The time to reach PADSS ≥9 was longer in the group BIS than in the group bolus. There was no difference between the two groups in terms of the satisfaction of the patient and the gynecologist. Conclusion: Administration of propofol as an infusion with BIS monitoring did not reduce the amount of propofol administered to patients during transvaginal oocyte retrieval. Funding: This research did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors.
- Open Access
- 1 January 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 7387600
The Effect of Ondansetron on the Analgesic Efficacy of Tramadol in Patients Undergoing Laparoscopic Cholecystectomy
Purpose. Investigating the effect of ondansetron on the efficacy of tramadol in patients undergoing laparoscopic cholecystectomy. Methods. Sixty American Society of Anesthesiologists (ASA) I‐II patients over the age of 18 who underwent laparoscopic cholecystectomy were included in this study. All patients were given 1 mg/kg tramadol intravenously (iv) during the intraoperative period. Patients were randomly assigned to receive either 4 mg ondansetron (Group O) or 2 mL saline (Group S). Postoperative tramadol consumption, pain score (NRS), intensity of nausea (NRS), presence of vomiting, consumption of rescue analgesics and antiemetics, and patient satisfaction were recorded. Results. A total of 60 patients were enrolled in the study; five patients were excluded due to deviation from the protocol. Data from 55 patients (Group O: 28 patients, Group S: 27 patients) were evaluated in the study. No differences between the two groups were detected for postoperative consumption of tramadol, pain score (NRS), intensity of nausea (NRS), presence of vomiting, consumption of rescue analgesics and antiemetics, and patient satisfaction. Conclusions. The results showed that coadministration of tramadol and ondansetron did not change tramadol consumption during the postoperative 24 hours after laparoscopic cholecystectomy. Clinical trial registration number is as follows: https://clinicaltrials.gov/ct2/show/NCT04745273—01/31/2021.
- 1 January 2022
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 2022 (1) , 7387600
Open AccessThe Effect of Ondansetron on the Analgesic Efficacy of Tramadol in Patients Undergoing Laparoscopic Cholecystectomy
Purpose. Investigating the effect of ondansetron on the efficacy of tramadol in patients undergoing laparoscopic cholecystectomy. Methods. Sixty American Society of Anesthesiologists (ASA) I‐II patients over the age of 18 who underwent laparoscopic cholecystectomy were included in this study. All patients were given 1 mg/kg tramadol intravenously (iv) during the intraoperative period. Patients were randomly assigned to receive either 4 mg ondansetron (Group O) or 2 mL saline (Group S). Postoperative tramadol consumption, pain score (NRS), intensity of nausea (NRS), presence of vomiting, consumption of rescue analgesics and antiemetics, and patient satisfaction were recorded. Results. A total of 60 patients were enrolled in the study; five patients were excluded due to deviation from the protocol. Data from 55 patients (Group O: 28 patients, Group S: 27 patients) were evaluated in the study. No differences between the two groups were detected for postoperative consumption of tramadol, pain score (NRS), intensity of nausea (NRS), presence of vomiting, consumption of rescue analgesics and antiemetics, and patient satisfaction. Conclusions. The results showed that coadministration of tramadol and ondansetron did not change tramadol consumption during the postoperative 24 hours after laparoscopic cholecystectomy. Clinical trial registration number is as follows: https://clinicaltrials.gov/ct2/show/NCT04745273—01/31/2021.
- 30 December 2016
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 41 (1) , 204-210
Comparison of Dexamethasone–Dimenhydrinate and Dexamethasone–Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients
Introduction Postoperative Nausea and Vomiting is one of the most common problems after implementation of general anesthesia. The incidence can reach 80% in high-risk patients, depending on the type of surgery. In our study, we aimed to compare dexamethasone–dimenhydrinate and dexamethasone–ondansetron combinations in prevention of nausea and vomiting in postoperative patients. Method Sixty 18–65-year-olds ASAI-II females who underwent rhinoplasty were included in the study. Patients were randomly included in two groups: Dexamethasone–dimenhydrinate group (group DD) and dexamethasone–ondansetron group (group DO). All patients received dexamethasone 8 mg iv after endotracheal intubation. Anesthesia continuation was established with sevoflurane, air–oxygen mixture and remifentanil infusion. At the 30th minute of the operation, group DO received ondansetron 4 mg iv and group DD received dimenhydrinate 1 mg/kg iv. For postoperative analgesia tramadol (1.5 mg/kg) iv, tenoksikam (20 mg) and afterward for postoperative patient-controlled tramadol was used. In the postoperative recovery room, nausea and vomiting were evaluated at the 30th, 60th, 120th minutes and at the end of 24 h. Total amount of tramadol was recorded. All results were statistically evaluated. Observations Demographics and Apfel risk scores of both groups were similar. Surgical operation duration (p = 0.038) and total preoperative remifentanil consumption were higher in group DD (p = 0.006). In group DO, nausea at 30 and 60 min (p = 0.001, p = 0.007), retching at 30 and 60 min (p = 0.002, p = 0.006) were higher than group DD. The additional antiemetic need in group DO was significantly higher at 30 min (p = 0.001). Postoperative analgesic consumption was similar in both groups. Result Our study revealed that dexamethasone–dimenhydrinate combination was more effective than dexamethasone–ondansetron in prevention of nausea and vomiting after rhinoplasty operations. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 30 December 2016
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 41 (1) , 204-210
Comparison of Dexamethasone–Dimenhydrinate and Dexamethasone–Ondansetron in Prevention of Nausea and Vomiting in Postoperative Patients
Introduction Postoperative Nausea and Vomiting is one of the most common problems after implementation of general anesthesia. The incidence can reach 80% in high-risk patients, depending on the type of surgery. In our study, we aimed to compare dexamethasone–dimenhydrinate and dexamethasone–ondansetron combinations in prevention of nausea and vomiting in postoperative patients. Method Sixty 18–65-year-olds ASAI-II females who underwent rhinoplasty were included in the study. Patients were randomly included in two groups: Dexamethasone–dimenhydrinate group (group DD) and dexamethasone–ondansetron group (group DO). All patients received dexamethasone 8 mg iv after endotracheal intubation. Anesthesia continuation was established with sevoflurane, air–oxygen mixture and remifentanil infusion. At the 30th minute of the operation, group DO received ondansetron 4 mg iv and group DD received dimenhydrinate 1 mg/kg iv. For postoperative analgesia tramadol (1.5 mg/kg) iv, tenoksikam (20 mg) and afterward for postoperative patient-controlled tramadol was used. In the postoperative recovery room, nausea and vomiting were evaluated at the 30th, 60th, 120th minutes and at the end of 24 h. Total amount of tramadol was recorded. All results were statistically evaluated. Observations Demographics and Apfel risk scores of both groups were similar. Surgical operation duration (p = 0.038) and total preoperative remifentanil consumption were higher in group DD (p = 0.006). In group DO, nausea at 30 and 60 min (p = 0.001, p = 0.007), retching at 30 and 60 min (p = 0.002, p = 0.006) were higher than group DD. The additional antiemetic need in group DO was significantly higher at 30 min (p = 0.001). Postoperative analgesic consumption was similar in both groups. Result Our study revealed that dexamethasone–dimenhydrinate combination was more effective than dexamethasone–ondansetron in prevention of nausea and vomiting after rhinoplasty operations. Level of Evidence IV This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- Open Access
- 12 September 2014
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 42 (6) , 1262-1271
Effect of ketamine versus alfentanil following midazolam in preventing emergence agitation in children after sevoflurane anaesthesia: A prospective randomized clinical trial
To investigate the effect of intranasal ketamine versus alfentanil in addition to oral midazolam for the prevention of emergence agitation in children. Children undergoing urological surgery with sevoflurane anaesthesia received oral midazolam 40 min before induction and were then randomly assigned to receive 2 mg/kg ketamine, 10 µg/kg alfentanil or 1 ml isotonic saline intranasally. Parental separation status and mask acceptance were assessed preoperatively. Emergence agitation was evaluated using a paediatric anaesthesia emergence delirium (PAED) score. Data from 78 children were evaluated in the study. There were no significant differences between the groups in demographic characteristics, recovery times or parental separation scores. Mask acceptance was significantly better in the ketamine group than in the saline group. The mean PAED score in the ketamine group was significantly better than in the other two groups, but was similar in the saline and alfentanil groups. The incidence of emergence agitation was 3.8%, 36.0% and 40.7% in the ketamine, alfentanil and saline groups, respectively. The addition of intranasal ketamine to oral midazolam significantly improved the quality of induction and reduced sevoflurane-induced emergence agitation, in children undergoing urological surgery.
- 12 September 2014
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 42 (6) , 1262-1271
Open AccessEffect of ketamine versus alfentanil following midazolam in preventing emergence agitation in children after sevoflurane anaesthesia: A prospective randomized clinical trial
To investigate the effect of intranasal ketamine versus alfentanil in addition to oral midazolam for the prevention of emergence agitation in children. Children undergoing urological surgery with sevoflurane anaesthesia received oral midazolam 40 min before induction and were then randomly assigned to receive 2 mg/kg ketamine, 10 µg/kg alfentanil or 1 ml isotonic saline intranasally. Parental separation status and mask acceptance were assessed preoperatively. Emergence agitation was evaluated using a paediatric anaesthesia emergence delirium (PAED) score. Data from 78 children were evaluated in the study. There were no significant differences between the groups in demographic characteristics, recovery times or parental separation scores. Mask acceptance was significantly better in the ketamine group than in the saline group. The mean PAED score in the ketamine group was significantly better than in the other two groups, but was similar in the saline and alfentanil groups. The incidence of emergence agitation was 3.8%, 36.0% and 40.7% in the ketamine, alfentanil and saline groups, respectively. The addition of intranasal ketamine to oral midazolam significantly improved the quality of induction and reduced sevoflurane-induced emergence agitation, in children undergoing urological surgery.
- 12 January 2012
- Vol. 78 (4) , 442-9
Effect of three different doses of ketamine prior to general anaesthesia on postoperative pain following Caesarean delivery: a prospective randomized study.
Ketamine is an analgesic suitable for the induction of anesthesia during Caesarean delivery. This double blind, randomized trial examined the effect of intravenous ketamine used before the induction of general anesthesia on morphine consumption, immediate and long term postoperative pain after Cesarean delivery. One hundred and forty term pregnant women undergoing elective Cesarean delivery were randomized into four groups (N.=35 each), placebo (0.9% normal saline), ketamine 0.25, 0.5, or 1 mg kg(-1) intravenously. In all patients 2-2.5 mg kg(-1) propofol was used for the induction of anesthesia, 0.6 mg kg(-1) rocuronium to facilitate the tracheal intubation and 50% oxygen in N2O and sevoflurane (end-tidal concentration of 1.2-1.3 %) for the maintenance of anesthesia. Postoperative analgesia was provided with intravenous morphine chloride patient-controlled analgesia (PCA) and rescue analgesia with intramuscular diclofenac sodium in the postoperative period. Apgar scores of the neonates and hemodynamic variables of the mothers were recorded during anaesthesia. Groups were compared regarding the cumulative morphine consumption and pain scores assessed with a numerical rating (0-10) scale at 2, 6, 12, 18, 24, and 48 h postoperatively. Postoperative side effects were recorded. Patients were evaluated for persistent postoperative pain at 2 weeks, 1 and 6 months, and 1 year. The cumulative morphine consumption at 48 hours after the surgery was the primary outcome of the study. There was no significant difference in terms of acute pain at 2 (P=0.3), 6 (P=0.7), 12 (P=0.4), 18 (P=0.4), 24 (P=0.8), and 48 (P=0.5) hours postoperatively. Cumulative morphine consumption obtained at 2 (P=0.9), 6 (P=0.5), 12 (P=0.4), 18 (P=0.4), 24 (P=0.1), and 48 (P=0.2) hours was also similar among the groups. Prolonged postoperative pain evaluated 2 weeks (P=0.3), 1 month (P=0.7), 6 months (P=0.1) and 1 year (P=0.3) after the operation was also similar among the groups. There was no significant difference in side effects among the groups during the postoperative 48 hours. Apgar scores at 1 min (P=0.5) and 5 mins (P=0.5) were similar among the groups. Maternal intraoperative hemodynamic parameters were similar among the groups. There was no difference regarding early and late postoperative pain and morphine consumption with ketamine at doses of 0.25, 0.5, and 1 mg kg(-1) in women undergoing Caesarean delivery under general anaesthesia, compared with the control group.
- 12 January 2012
- Vol. 78 (4) , 442-9
Effect of three different doses of ketamine prior to general anaesthesia on postoperative pain following Caesarean delivery: a prospective randomized study.
Ketamine is an analgesic suitable for the induction of anesthesia during Caesarean delivery. This double blind, randomized trial examined the effect of intravenous ketamine used before the induction of general anesthesia on morphine consumption, immediate and long term postoperative pain after Cesarean delivery. One hundred and forty term pregnant women undergoing elective Cesarean delivery were randomized into four groups (N.=35 each), placebo (0.9% normal saline), ketamine 0.25, 0.5, or 1 mg kg(-1) intravenously. In all patients 2-2.5 mg kg(-1) propofol was used for the induction of anesthesia, 0.6 mg kg(-1) rocuronium to facilitate the tracheal intubation and 50% oxygen in N2O and sevoflurane (end-tidal concentration of 1.2-1.3 %) for the maintenance of anesthesia. Postoperative analgesia was provided with intravenous morphine chloride patient-controlled analgesia (PCA) and rescue analgesia with intramuscular diclofenac sodium in the postoperative period. Apgar scores of the neonates and hemodynamic variables of the mothers were recorded during anaesthesia. Groups were compared regarding the cumulative morphine consumption and pain scores assessed with a numerical rating (0-10) scale at 2, 6, 12, 18, 24, and 48 h postoperatively. Postoperative side effects were recorded. Patients were evaluated for persistent postoperative pain at 2 weeks, 1 and 6 months, and 1 year. The cumulative morphine consumption at 48 hours after the surgery was the primary outcome of the study. There was no significant difference in terms of acute pain at 2 (P=0.3), 6 (P=0.7), 12 (P=0.4), 18 (P=0.4), 24 (P=0.8), and 48 (P=0.5) hours postoperatively. Cumulative morphine consumption obtained at 2 (P=0.9), 6 (P=0.5), 12 (P=0.4), 18 (P=0.4), 24 (P=0.1), and 48 (P=0.2) hours was also similar among the groups. Prolonged postoperative pain evaluated 2 weeks (P=0.3), 1 month (P=0.7), 6 months (P=0.1) and 1 year (P=0.3) after the operation was also similar among the groups. There was no significant difference in side effects among the groups during the postoperative 48 hours. Apgar scores at 1 min (P=0.5) and 5 mins (P=0.5) were similar among the groups. Maternal intraoperative hemodynamic parameters were similar among the groups. There was no difference regarding early and late postoperative pain and morphine consumption with ketamine at doses of 0.25, 0.5, and 1 mg kg(-1) in women undergoing Caesarean delivery under general anaesthesia, compared with the control group.
- 1 January 2012
- Published by Makale Sistemi/Geomes in Yeditepe Medical Journal
- Vol. 22 (1)
A COMPARISON OF TWO DIFFERENT DOSES OF BUPIVACAINE IN CAUDAL ANESTHESIA FOR NEONATAL CIRCUMCISION: A RANDOMIZED CLINICAL TRIAL
We aimed to compare the analgesia quality of caudal block of low volume, high concentration bupivacaine to the conventionally used volumes and concentrations of the drug in neonates undergoing circumcision with sole caudal anesthesia.
- 1 January 2012
- Published by Makale Sistemi/Geomes in Yeditepe Medical Journal
- Vol. 22 (1)
A COMPARISON OF TWO DIFFERENT DOSES OF BUPIVACAINE IN CAUDAL ANESTHESIA FOR NEONATAL CIRCUMCISION: A RANDOMIZED CLINICAL TRIAL
We aimed to compare the analgesia quality of caudal block of low volume, high concentration bupivacaine to the conventionally used volumes and concentrations of the drug in neonates undergoing circumcision with sole caudal anesthesia.